Annual General Meeting 2014
Lysaker, 13 May 2014
The Annual General Meeting in PCI Biotech Holding ASA was held 13 May 2014. All propositions according the call were approved. Minutes of the Annual General Meeting is attached (in Norwegian only).
In the Annual General Meeting, Hilde H. Steineger was elected new Board Member of PCI Biotech Holding ASA.
Hilde H. Steineger (b. 1966) is a Norwegian citizen with a PhD in medical biochemistry and with over 20 years experience in the intersection of research and commercialization from different parts of the pharmaceutical industry. She has since 2009 worked in Pronova, now part of the BASF Group, where she is currently Head of Global Omega-3 Innovation Management. She began her career at Nycomed Pharma in 1999, first in clinical development and then with international marketing. In 2001, she was an analyst at Nordea responsible for coverage of the biotechnology and pharmaceutical industries on the Oslo Stock Exchange and Copenhagen Stock Exchange. After a period as an independent consultant (2003-2005) she became a senior associate in Neomed Management, an international investment company with focus on the health industry. Hilde also has extensive board experience in the pharmaceutical industry (including Algeta ASA and Clavis Pharma ASA) and she currently has two other board positions in the sector: Cortendo AB and Weifa AS.
For more information visit: www.pcibiotech.com
For further information, please contact
Ronny Skuggedal, CFO
rs@pcibiotech.no
Mobile: +47 9400 5757